| Database ID | Agent | Target | Cancer Type | Detail |
| DB00826 | ramucirumab | Vascular endothelial growth factor receptor 2 | non small cell lung cancer | view |
| DB00827 | afatinib and cetuximab | NA | lung cancer | view |
| DB00828 | PX866 | PI3K gamma | non small cell lung cancer | view |
| DB00829 | everolimus | Serine/threonineprotein kinase mTOR | smallcell lung cancer | view |
| DB00830 | sunitinib | FL cytokine receptor
Mast/stem cell growth factor receptor
Vascular endothelial growth factor receptor 2
Plateletderived growth factor receptor | advanced solid tumors | view |
| DB00831 | sunitinib | FL cytokine receptor
Mast/stem cell growth factor receptor
Vascular endothelial growth factor receptor 2
Plateletderived growth factor receptor | advanced solid tumors | view |
| DB00832 | sunitinib | FL cytokine receptor
Mast/stem cell growth factor receptor
Vascular endothelial growth factor receptor 2
Plateletderived growth factor receptor | advanced solid tumors | view |
| DB00833 | sunitinib | FL cytokine receptor
Mast/stem cell growth factor receptor
Vascular endothelial growth factor receptor 2
Plateletderived growth factor receptor | advanced solid tumors | view |
| DB00834 | erlotinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00835 | sunitinib | FL cytokine receptor
Mast/stem cell growth factor receptor
Vascular endothelial growth factor receptor 2
Plateletderived growth factor receptor | non small cell lung cancer | view |
| DB00836 | erlotinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00837 | AZD6244 | Dual specificity mitogenactivated protein kinase kinase | advanced solid tumors | view |
| DB00838 | ramucirumab | Vascular endothelial growth factor receptor 2 | advanced solid tumors | view |
| DB00839 | mapatumumab | Tumor necrosis factor receptor superfamily member 10A | advanced solid tumors | view |
| DB00840 | Afatinib erlotinib | NA | non small cell lung cancer | view |